Few Eyebrows Up

Nov 02, 2018

Some experts have raised concerned about 23andMe's new direct-to-consumer pharmacogenetic tests, Time reports.

The US Food and Drug Administration earlier this week gave 23andMe authorization to sell tests for 33 variants linked to the ability to break down certain drugs, as GenomeWeb has reported.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lawsuit on Not Knowing Father's Test Result

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

Lots and Lots of Triglycerides

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

Image Errors Investigated

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

PNAS Studies on Supercentenarians, Blood Cell Differentiation in AML, Beetle Evolution

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.

Menu

Few Eyebrows Up

To read the full story....

The Scan

Lawsuit on Not Knowing Father's Test Result

Lots and Lots of Triglycerides

Image Errors Investigated

PNAS Studies on Supercentenarians, Blood Cell Differentiation in AML, Beetle Evolution

What's Popular?

Qiagen Says It Is Fielding Acquisition Offers

Roche to Buy up to $2B of Notes

Personalis, Merck KGaA to Study Cancer Biomarkers Using Immunogenomics Platform

Bio-Rad Laboratories, Diagenode Partner to Offer Droplet Digital PCR ATAC-Seq Services

Exact Sciences Marker Panel Detects Early Liver Cancer With Triple Sensitivity of Current Biomarker

Sponsorships